• 53930
• May 04, 2024

Zydus’ biopharma arm acquires global proprietary rights for Progeria treatment

Sentynl, under Zydus Lifesciences, acquired global rights for Zokinvy, the first FDA-approved Progeria treatment. An acquisition milestone in expanding the rare disease medicines portfolio, focusing on supporting patients.

• News Source Indiatimes (Click to view full news): CLICK HERE

• Category:
• Business

• Share: